Stockscreener 앱 받기
0.679
6.26%
0.04
시간 외 거래:
.65
-0.029
-4.27%
전일 마감가:
$0.639
열려 있는:
$0.65
하루 거래량:
22,173
Relative Volume:
0.14
시가총액:
$2.64M
수익:
$2.28M
순이익/손실:
$-3.71M
주가수익비율:
-0.2021
EPS:
-3.36
순현금흐름:
$-3.60M
1주 성능:
+1.34%
1개월 성능:
+29.43%
6개월 성능:
-10.27%
1년 성능:
-50.07%
1일 변동 폭
$0.65
$0.7028
1주일 범위
$0.62
$0.739
52주 변동 폭
$0.4575
$1.5499
Nanovibronix Inc Stock (NAOV) Company Profile
명칭
Nanovibronix Inc
전화
(914) 233-3004
주소
969 PRUITT AVE,, TYLER
NAOV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| NAOV | 0.679 | 2.64M | 2.28M | -3.71M | -3.60M | -3.36 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Nanovibronix Inc 주식(NAOV)의 최신 뉴스
NanoVibronix Third Quarter 2024 Earnings: US$0.36 loss per share (vs US$0.42 loss in 3Q 2023) - Yahoo Finance
Armistice Capital, LLC Expands Stake in NanoVibronix Inc - GuruFocus.com
NanoVibronix Inc (NAOV) Quarterly 10-Q Report - Quartzy
NanoVibronix expands global reach, eyes new markets By Investing.com - Investing.com South Africa
NanoVibronix expands global reach, eyes new markets - Investing.com
NanoVibronix Expands Global Reach with NHS Approval, South African Distribution Deal | NAOV Stock News - StockTitan
A look into NanoVibronix Inc (NAOV)’s deeper side - SETE News
Ratios in Focus: Analyzing NanoVibronix Inc (NAOV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
NanoVibronix Inc (NAOV) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
NanoVibronix faces potential Nasdaq delisting - Investing.com India
NanoVibronix faces potential Nasdaq delisting By Investing.com - Investing.com Canada
NanoVibronix Forges Potential New Distribution Deal - MPO-mag
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - StockTitan
NanoVibronix stock hits 52-week low at $0.52 - Investing.com India
NanoVibronix stock hits 52-week low at $0.52 By Investing.com - Investing.com Canada
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Australia
NanoVibronix explores UroShield distribution in Israel - Investing.com
NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan
NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE
Audit raises transparency concerns in IPO utilisation - The Business Post
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine
NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers
Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver
NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech
NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World
NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World
NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com
NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan
NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com
NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com
NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance
NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World
NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com
NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex
Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World
NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World
Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail
NanoVibronix Announces Reverse Stock Split - Quantisnow
NanoVibronix Reports Progress on Three Clinical Trials - Yahoo News UK
NanoVibronix’s PainShield Included in V.A. Contract - MPO-mag
Nanovibronix Inc (NAOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):